Log In
BCIQ
Print this Print this
 

CGEN-671

  Manage Alerts
Collapse Summary General Information
Company Compugen Ltd.
DescriptionMembrane splice variant of CD55
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationEpithelial cancer
Indication DetailsTreat epithelial cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today